Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Celgene Corp., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
Cash and cash equivalents	9,604)	7,214)	5,433)	4,234)	2,480)	1,503)	2,819)	7,013)	5,511)	6,660)	5,273)	6,170)	5,523)	5,064)	4,446)	4,880)	6,017)	4,531)	4,368)	4,122)	3,743)	3,220)	2,397)
Debt securities available-for-sale	14)	613)	664)	496)	66)	79)	68)	3,219)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Equity investments with readily determinable fair values	1,279)	1,496)	1,594)	1,312)	1,832)	1,828)	1,853)	1,810)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Marketable securities available-for-sale	—)	—)	—)	—)	—)	—)	—)	—)	6,248)	3,480)	3,588)	1,800)	1,346)	1,340)	1,262)	1,672)	1,489)	2,961)	2,946)	3,425)	3,118)	2,994)	2,714)
Accounts receivable, net of allowances	2,374)	2,451)	2,327)	2,066)	2,120)	2,064)	1,991)	1,921)	1,816)	1,729)	1,614)	1,621)	1,586)	1,515)	1,420)	1,421)	1,272)	1,273)	1,179)	1,167)	1,068)	1,124)	1,073)
Inventory	451)	464)	442)	458)	510)	555)	536)	541)	537)	533)	509)	498)	508)	490)	471)	443)	421)	414)	387)	393)	372)	360)	348)
Deferred income taxes	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	250)	11)	11)	12)	26)	27)	26)
Other current assets	732)	445)	521)	501)	819)	824)	605)	388)	671)	734)	633)	779)	613)	760)	788)	985)	704)	692)	775)	594)	509)	383)	386)
Current assets	14,454)	12,683)	10,981)	9,067)	7,827)	6,853)	7,872)	14,892)	14,783)	13,136)	11,617)	10,868)	9,576)	9,169)	8,386)	9,401)	10,152)	9,884)	9,665)	9,713)	8,836)	8,107)	6,942)
Property, plant and equipment, net	1,415)	1,400)	1,383)	1,367)	1,313)	1,292)	1,251)	1,070)	1,002)	989)	958)	930)	891)	854)	840)	814)	702)	675)	650)	643)	624)	605)	596)
Intangible assets, net	16,387)	15,991)	16,101)	16,213)	16,342)	16,470)	16,599)	8,436)	10,137)	10,218)	10,307)	10,392)	10,499)	10,587)	10,764)	10,858)	10,716)	3,938)	4,002)	4,068)	4,132)	4,326)	2,773)
Goodwill	8,003)	8,003)	8,003)	8,003)	8,004)	8,004)	8,018)	4,866)	4,866)	4,866)	4,866)	4,866)	4,866)	4,877)	4,877)	4,879)	4,742)	2,191)	2,191)	2,191)	2,191)	2,191)	2,041)
Other non-current assets	1,104)	1,106)	1,171)	830)	729)	825)	816)	877)	948)	1,097)	1,072)	1,031)	922)	1,075)	1,098)	1,101)	1,057)	1,058)	972)	726)	621)	373)	353)
Non-current assets	26,909)	26,500)	26,658)	26,413)	26,388)	26,591)	26,684)	15,249)	16,953)	17,170)	17,203)	17,218)	17,178)	17,393)	17,578)	17,653)	17,217)	7,862)	7,815)	7,628)	7,567)	7,495)	5,763)
Total assets	41,363)	39,183)	37,639)	35,480)	34,215)	33,444)	34,556)	30,141)	31,736)	30,306)	28,820)	28,086)	26,754)	26,562)	25,964)	27,053)	27,369)	17,746)	17,481)	17,340)	16,403)	15,602)	12,705)

Assets: Selected Items

Download chart

Balance sheet item	Description	The company
Current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Celgene Corp. current assets increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Property, plant and equipment, net	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Celgene Corp. property, plant and equipment, net increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Non-current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.	Celgene Corp. non-current assets decreased from Q1 2019 to Q2 2019 but then increased from Q2 2019 to Q3 2019 exceeding Q1 2019 level.
Total assets	Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Celgene Corp. total assets increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.

Current Assets: Selected Items

Download chart

Balance sheet item	Description	The company
Cash and cash equivalents	Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.	Celgene Corp. cash and cash equivalents increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Marketable securities available-for-sale	Amount of investment in marketable security, classified as current.
Accounts receivable, net of allowances	Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.	Celgene Corp. accounts receivable, net of allowances increased from Q1 2019 to Q2 2019 but then slightly decreased from Q2 2019 to Q3 2019 not reaching Q1 2019 level.
Inventory	Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.	Celgene Corp. inventory increased from Q1 2019 to Q2 2019 but then slightly decreased from Q2 2019 to Q3 2019 not reaching Q1 2019 level.

Celgene Corp. (NASDAQ:CELG)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data